Literature DB >> 30382593

Surgical Resection Versus Transarterial Chemoembolization for Intermediate Stage Hepatocellular Carcinoma (BCLC-B): An Unsolved Question.

Ismail Labgaa1, Nicolas Demartines1, Emmanuel Melloul1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30382593     DOI： 10.1002/hep.30338

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients.

Authors:  Jing Chen; Dan-Xue Zheng; Xing-Juan Yu; Hong-Wei Sun; Yi-Tuo Xu; Yao-Jun Zhang; Jing Xu
Journal:  Oncoimmunology       Date:  2019-08-15       Impact factor: 8.110

2.  Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies.

Authors:  Kazuya Kariyama; Kazuhiro Nouso; Akiko Wakuta; Ayano Oonishi; Hidenori Toyoda; Toshifumi Tada; Atsushi Hiraoka; Kunihiko Tsuji; Ei Itobayashi; Toru Ishikawa; Koichi Takaguchi; Akemi Tsutsui; Noritomo Shimada; Takashi Kumada
Journal:  Liver Cancer       Date:  2019-10-22       Impact factor: 11.740

3.  A nomogram for predicting the risk of postoperative recurrence of hepatitis B virus-related hepatocellular carcinoma in patients with high preoperative serum glutamyl transpeptidase.

Authors:  Jia-Si Zhang; Zhi-Heng Wang; Xing-Gang Guo; Ji Zhang; Jun-Sheng Ni
Journal:  J Gastrointest Oncol       Date:  2022-02

4.  Single Large Nodule (>5 cm) Prognosis in Hepatocellular Carcinoma: Kinship with Barcelona Clinic Liver Cancer (BCLC) Stage A or B?

Authors:  Li Wan; Ding-Hui Dong; Xiao-Ning Wu; Hong-Fan Ding; Qiang Lu; Yong Tian; Xu-Feng Zhang; Wenzhi Li
Journal:  Med Sci Monit       Date:  2020-10-16

5.  Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias.

Authors:  Yi-Hao Yen; Yu-Fan Cheng; Jing-Houng Wang; Chih-Che Lin; Chien-Hung Chen; Chih-Chi Wang
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

6.  Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis.

Authors:  A Bogdanovic; P Bulajic; D Masulovic; N Bidzic; M Zivanovic; D Galun
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

7.  HCG18 Participates in Vascular Invasion of Hepatocellular Carcinoma by Regulating Macrophages and Tumor Stem Cells.

Authors:  Liwei Zhang; Zhiwei Wang; Mingxing Li; Peng Sun; Tao Bai; Wang Wang; Hualong Bai; Jianjun Gou; Zhiju Wang
Journal:  Front Cell Dev Biol       Date:  2021-08-30

8.  The construction of the novel magnetic prodrug Fe3O4@DOX and its antagonistic effects on hepatocarcinoma with low toxicity.

Authors:  Jun Li; Liang Li; Yang Lv; Hao Zou; Yanping Wei; Fei Nie; Wanli Duan; Maidinamu Sedike; Liang Xiao; Mei Wang
Journal:  RSC Adv       Date:  2020-08-05       Impact factor: 4.036

9.  Comparison of Partial Hepatectomy and Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ismail Labgaa; Patrick Taffé; David Martin; Daniel Clerc; Myron Schwartz; Norihiro Kokudo; Alban Denys; Nermin Halkic; Nicolas Demartines; Emmanuel Melloul
Journal:  Liver Cancer       Date:  2020-01-28       Impact factor: 11.740
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.